Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 4

Results: 15

Construction of an immune predictive model and identification of TRIP6 as a prognostic marker and therapeutic target of CRC by integration of single-cell and bulk RNA-seq data.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03658-w

By:

Liu, Wenjun;
Luo, Xitu;
Zhang, Zilang;
Chen, Yepeng;
Dai, Yongliang;
Deng, Jianzhong;
Yang, Chengyu;
Liu, Hao

Publication type:

Article

Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03657-x

By:

Zhang, Jianguo;
Li, Yangyi;
Dai, Weijing;
Tang, Fang;
Wang, Lanqing;
Wang, Zhiying;
Li, Siqi;
Ji, Qian;
Zhang, Junhong;
Liao, Zhengkai;
Yu, Jing;
Xu, Yu;
Gong, Jun;
Hu, Jing;
Li, Jie;
Guo, Xiuli;
He, Fajian;
Han, Linzhi;
Gong, Yan;
Ouyang, Wen

Publication type:

Article

Neutrophils seeking new neighbors: radiotherapy affects the cellular framework and the spatial organization in a murine breast cancer model.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03653-1

By:

Reichardt, C. M.;
Muñoz-Becerra, M.;
Rius Rigau, A.;
Rückert, M.;
Fietkau, R.;
Schett, G.;
Gaipl, U. S.;
Frey, B.;
Muñoz, L. E.

Publication type:

Article

Mechanism exploration of Zoledronic acid combined with PD-1 in the treatment of hepatocellular carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03652-2

By:

Fan, Xinru;
Yan, Zijun;
Lin, Yunkai;
Wang, Qing;
Jiang, Li;
Yao, Xiaomeng;
Dong, Liwei;
Chen, Lei;
Zhao, Tuan;
Zhao, Jieqiong;
Hu, Heping;
Wang, Hui

Publication type:

Article

Integrating molecular subtype and CD8<sup>+</sup> T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03651-3

By:

Li, Bingyu;
Jin, Kaifeng;
Liu, Zhaopei;
Su, Xiaohe;
Xu, Ziyue;
Liu, Ge;
Xu, Jingtong;
Liu, Hailong;
Chang, Yuan;
Wang, Yiwei;
Zhu, Yu;
Wang, Zewei;
Xu, Le;
Zhang, Weijuan

Publication type:

Article

Riboflavin-LSD1 axis participates in the in vivo tumor-associated macrophage morphology in human colorectal liver metastases.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03645-1

By:

Soldani, Cristiana;
De Simone, Giulia;
Polidoro, Michela Anna;
Morabito, Aurelia;
Franceschini, Barbara;
Colombo, Federico Simone;
Anselmo, Achille;
Milana, Flavio;
Lleo, Ana;
Torzilli, Guido;
Pastorelli, Roberta;
Donadon, Matteo;
Brunelli, Laura

Publication type:

Article

A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03640-6

By:

Falchook, Gerald S.;
Reeves, James;
Gandhi, Sunil;
Spigel, David R.;
Arrowsmith, Edward;
George, Daniel J.;
Karlix, Janet;
Pouliot, Gayle;
Hattersley, Maureen M.;
Gangl, Eric T.;
James, Gareth D.;
Thompson, Jeff;
Russell, Deanna L.;
Patel, Bhavickumar;
Kumar, Rakesh;
Lim, Emerson

Publication type:

Article

Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-023-03596-z

By:

Bian, Zhuoqiong;
Wu, Xiaoling;
Chen, Qing;
Gao, Qing;
Xue, Xiang;
Wang, Yidong

Publication type:

Article

Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-023-03580-7

By:

Yue, Jiawei;
Guo, Hui;
Xu, Peng;
Ma, Jinhong;
Shi, Weifeng;
Wu, Yumin

Publication type:

Article

Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03667-9

By:

Zhang, Kaiqi;
Xu, Yuan;
Chang, Xusheng;
Xu, Caili;
Xue, Wenjing;
Ding, Dan;
Nie, Mingming;
Cai, Hui;
Xu, Jun;
Zhan, Lu;
Han, Jiangbo;
Cai, Tiancai;
Ju, Dianwen;
Feng, Li;
Zhang, Xuyao;
Yin, Kai

Publication type:

Article

Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03660-2

By:

Yan, Huan;
Song, Lianxi;
Li, Yizhi;
Xu, Qinqin;
Guo, Wenhuan;
Lin, Shaoding;
Jiang, Wenjuan;
Wang, Zhan;
Deng, Li;
Huang, Zhe;
Qin, Haoyue;
Zhang, Xing;
Tong, Fan;
Zhang, Ruiguang;
Liu, Zhaoyi;
Zhang, Lin;
Yu, Juan;
Dong, Xiaorong;
Gong, Qian;
Deng, Jun

Publication type:

Article

Ectopic CXCR2 expression cells improve the anti-tumor efficiency of CAR-T cells and remodel the immune microenvironment of pancreatic ductal adenocarcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03648-y

By:

Dai, Zhengjie;
Lin, Xuan;
Wang, Xu;
Zou, Xuan;
Yan, Yu;
Wang, Ruijie;
Chen, Yusheng;
Tasiheng, Yesiboli;
Ma, Mingjian;
Cheng, He;
Yu, Xianjun;
Liu, Chen

Publication type:

Article

Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03643-3

By:

Seiwert, Tanguy Y.;
Wildsmith, Sophie;
Fayette, Jérôme;
Harrington, Kevin;
Gillison, Maura;
Ahn, Myung-Ju;
Takahashi, Shunji;
Weiss, Jared;
Machiels, Jean-Pascal;
Baxi, Shrujal;
Baker, Valerie;
Evans, Brent;
Morsli, Nassim;
Jill Walker;
Real, Katia;
L'Hernault, Anne;
Psyrri, Amanda

Publication type:

Article

Size selection of intrahepatic lesions for cryoablation contributes to abscopal effect and long-term survival in patients with liver metastatic melanoma receiving PD-1 blockade therapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03637-1

By:

Shen, Lujun;
Tan, Hongtong;
Nie, Juan;
Jiang, Yiquan;
Nuerhashi, Gulijiayina;
Qi, Han;
Cao, Fei;
Wen, Chunyong;
Chen, Shuanggang;
Zhang, Tianqi;
Zheng, Wei;
Liu, Peng;
Liu, Ying;
Huang, Tao;
Li, Dandan;
Zhang, Xiaoshi;
Fan, Weijun

Publication type:

Article

Clinical immunotherapy in pancreatic cancer.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 4, p. 1, doi. 10.1007/s00262-024-03632-6

By:

Ye, Xiaorong;
Yu, Yue;
Zheng, Xiaohu;
Ma, Hongdi

Publication type:

Article